This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
1079 |
6. Filter based on genotype QC (FinnGen only) |
1079 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_CNS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Encephalitis
based on the number of shared cases.
Similar with more cases:
- Inflammatory diseases of the central nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1079 | 603 | 476 |
| Unadjusted period prevalence (%) | 0.21 | 0.21 | 0.21 |
| Median age at first event (years) | 47.12 | 42.96 | 52.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 957
- Matched controls
- 9568
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
323.0
406
*
TAB00
NOMESCO Finland
Lumbar puncture
18.1
157.6
257
190
A86
ICD-10 Finland
Unspecified viral encephalitis
+∞
113.9
107
*
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
110.6
104
*
32309
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Unspecified
+∞
105.2
99
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.4
96.3
232
351
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
+∞
90.0
85
*
AA1AD
NOMESCO Finland
CT of head and brain
3.9
68.3
355
1253
XA800
NOMESCO Finland
Neuropsychological investigation
8.7
61.0
139
184
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.9
59.7
113
106
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.1
56.9
148
239
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.4
54.0
116
138
N03AX14
ATC
levetiracetam; systemic
11.3
50.5
98
96
5AB01
NOMESCO Finland
NA
252.3
47.4
48
*
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
+∞
45.2
43
*
A87.9
ICD-10 Finland
Viral meningitis, unspecified
235.8
44.3
45
*
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
44.1
42
*
G05.1*J09
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in influenza caused by certain identified influenza viruses
+∞
43.0
41
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.6
42.7
221
733
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.9
41.6
78
71
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.6
41.0
154
381
N03AF02
ATC
oxcarbazepine; oral
7.7
37.0
89
126
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
+∞
34.6
33
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.1
34.5
115
249
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
10.0
33.8
69
74
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
16.4
32.9
53
34
32300
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Encephalitis postinfectiosa
+∞
32.5
31
*
R4120
NOMESCO Finland
Occupational therapy
4.8
32.1
113
259
ZX120
NOMESCO Finland
Intravenous
3.6
30.7
151
471
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
30.4
199
766
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
+∞
30.4
29
*
B00.4
ICD-10 Finland
Herpesviral encephalitis
+∞
30.4
29
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
15.5
30.3
50
34
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
30.0
436
2599
G03.9
ICD-10 Finland
Meningitis, unspecified
82.8
28.9
32
*
G04.0
ICD-10 Finland
Acute disseminated encephalitis
+∞
28.3
27
*
N03AG01
ATC
valproic acid; systemic, rectal
4.4
27.8
106
263
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
27.4
129
387
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.4
27.3
57
64
R50.9
ICD-10 Finland
Fever, unspecified
2.9
27.1
190
757
G35
ICD-10 Finland
Multiple sclerosis
10.9
27.0
52
50
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
17.5
26.8
42
25
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
19.8
26.7
40
21
3238B
ICD-9 Finland
Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS,ENCEPHALOMYELITIS) VIROSA]
+∞
26.2
25
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
24.3
243
1184
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
57.6
24.1
28
5
A28
ICPC
Limited function/disability NOS
2.8
23.7
169
679
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
25.4
23.2
32
13
R51.80
ICD-10 Finland
Headache
2.6
23.0
185
795
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
22.5
193
863
R4110
NOMESCO Finland
Physiotherapy
2.2
22.4
283
1534
N03AX16
ATC
pregabalin; oral
2.3
22.2
252
1299
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
117.7
21.7
23
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
21.3
239
1222
N03AX12
ATC
gabapentin; oral
2.5
21.1
182
812
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
8.9
21.1
45
53
Z2445
NOMESCO Finland
Psychologist
4.3
20.4
79
198
R41.0
ICD-10 Finland
Disorientation, unspecified
6.1
20.4
56
96
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
20.4
183
834
2AB04
NOMESCO Finland
NA
49.1
20.2
24
5
WX892
NOMESCO Finland
Monitored bed care
3.5
20.1
100
312
R4150
NOMESCO Finland
Neuropsychological rehabilitation
12.9
20.0
35
28
G04.2
ICD-10 Finland
Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified
+∞
19.9
19
*
G05.1*J10.8
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in influenza caused by other identified influenza virus
+∞
19.9
19
*
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
19.9
19
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
19.8
130
493
N03AX18
ATC
lacosamide; systemic
13.1
19.0
33
26
N05BA09
ATC
clobazam; oral
15.4
18.5
30
20
N99
ICPC
Neurological disease other
10.6
17.8
34
33
H02AB06
ATC
prednisolone; systemic
1.8
17.8
436
2990
R33
ICD-10 Finland
Retention of urine
3.3
17.8
92
296
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
17.5
147
641
183
Kela drug reimbursment
Lamotrigin and topiramate
10.0
17.2
34
35
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
16.8
293
1775
N03AB02
ATC
phenytoin; systemic
10.0
16.8
33
34
G05.1*A85.0
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis (in) enteroviral
+∞
16.7
16
*
N71
ICPC
Meningitis/encephalitis
+∞
16.7
16
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
16.7
141
619
Z3231
NOMESCO Finland
Registered nurse
2.0
16.6
281
1681
H02AB09
ATC
hydrocortisone; systemic
5.9
16.5
46
81
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
14.6
16.4
27
19
Z3226
NOMESCO Finland
Physiotherapist
2.1
16.0
198
1042
TKC20
NOMESCO Finland
Catheterisation of bladder
3.2
16.0
89
299
R20.2
ICD-10 Finland
Paraesthesia of skin
3.1
15.7
90
311
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.7
15.6
111
441
M05BA04
ATC
alendronic acid; oral
3.0
15.6
94
336
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
162.5
15.5
16
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.6
15.5
71
208
109
Kela drug reimbursment
Multiple sclerosis
9.6
15.0
30
32
6BA02
NOMESCO Finland
NA
15.3
14.9
24
16
Z2221
NOMESCO Finland
Medical doctor
1.9
14.6
279
1727
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
152.2
14.5
15
*
F05.9
ICD-10 Finland
Delirium, unspecified
6.2
14.4
38
63
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.8
14.3
40
71
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
14.3
77
256
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
22.7
14.3
20
9
L04AA06
ATC
mycophenolic acid; systemic
6.4
14.2
37
60
XA400
NOMESCO Finland
EEG
12.2
14.1
25
21
ZXY02
NOMESCO Finland
Neuropsychologist
14.7
14.1
23
16
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
6.4
13.9
36
58
ZXD05
NOMESCO Finland
Urgent procedure
1.8
13.7
308
2006
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
13.6
79
276
32308
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Alia definita
+∞
13.6
13
*
J01MA12
ATC
levofloxacin; systemic
2.1
13.5
175
935
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
13.1
13.4
23
18
H02AB07
ATC
prednisone; oral
2.2
13.4
148
737
WW400
NOMESCO Finland
Plasmaferesis
26.2
13.4
18
7
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.6
13.3
38
70
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
40.7
13.2
16
*
L28
ICPC
Limited function/disability (L)
2.1
13.1
152
773
N03AX09
ATC
lamotrigine; oral
3.3
13.0
65
204
N03AF01
ATC
carbamazepine; oral, rectal
3.4
12.9
64
200
J01DB01
ATC
cefalexin; oral
1.8
12.6
758
6511
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
12.5
73
257
R42
ICD-10 Finland
Dizziness and giddiness
1.9
12.4
199
1149
L04AX01
ATC
azathioprine; systemic
3.3
12.4
63
201
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.9
12.3
76
277
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
12.2
84
327
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
12.1
330
2266
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
9.4
12.0
24
26
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
11.9
94
396
N03AX11
ATC
topiramate; oral
5.2
11.8
36
72
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
11.6
172
964
J01AA02
ATC
doxycycline; systemic
1.7
11.5
684
5753
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
11.5
162
887
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
11.5
11
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.7
11.3
78
304
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.7
11.2
25
33
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
9.4
11.0
22
24
G41.9
ICD-10 Finland
Status epilepticus, unspecified
10.2
11.0
21
21
C03CA01
ATC
furosemide; systemic
1.8
10.9
231
1458
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
43.8
10.9
13
*
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
8.4
10.8
23
28
JN4BD
NOMESCO Finland
Extensive body CT
2.3
10.8
103
477
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
21.7
10.7
15
7
R11
ICD-10 Finland
Nausea and vomiting
2.5
10.7
89
384
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.9
10.6
65
234
Z2446
NOMESCO Finland
Social worker
2.6
10.6
80
329
G73.7*M32.1
ICD-10 Finland
Myopathy in systemic lupus erythematosus
111.2
10.4
11
*
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
+∞
10.4
10
*
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
+∞
10.4
10
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.5
10.4
26
41
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.5
10.3
81
339
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.3
10.2
30
58
SPAT1255
SPAT
Intravenous administration of medicine
2.7
10.1
67
255
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
10.1
86
377
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.2
10.0
26
43
N05AH04
ATC
quetiapine; oral
1.9
10.0
163
944
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.1
10.0
53
176
J05AB11
ATC
valaciclovir; oral
2.0
9.9
130
693
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.0
9.9
26
44
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.8
9.8
63
237
R4130
NOMESCO Finland
Speech therapy
4.1
9.6
36
90
G40
ICD-10 Finland
Epilepsy
7.6
9.4
21
28
A02BC02
ATC
pantoprazole; systemic
1.5
9.4
554
4524
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
8.1
9.4
20
25
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.3
9.4
33
78
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
9.3
451
3520
SPAT1167
SPAT
Insertion of urinary catheter
4.1
9.1
34
85
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.4
9.1
42
126
G40.89
ICD-10 Finland
Other epilepsy
11.6
9.1
16
14
N05BA01
ATC
diazepam; systemic, rectal
1.9
9.0
132
731
N28
ICPC
Limited function/disability (N)
5.6
8.9
25
46
M03BX01
ATC
baclofen; systemic
4.9
8.9
28
59
SPAT1254
SPAT
Administration of medicine
1.9
8.9
138
782
5CM18
NOMESCO Finland
NA
14.2
8.7
14
10
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
8.6
63
256
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
5.6
8.6
24
44
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.6
8.6
62
250
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.2
8.6
86
408
L04AX07
ATC
dimethyl fumarate; oral
16.5
8.6
13
8
RS221
NOMESCO Finland
NA
5.2
8.5
25
49
ZXD35
NOMESCO Finland
Usual procedure
3.2
8.4
42
134
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.1
8.4
45
151
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
90.8
8.4
9
*
G61.0
ICD-10 Finland
Guillain-Barré syndrome
12.9
8.4
14
11
J01FF01
ATC
clindamycin; systemic
1.6
8.4
232
1570
F07.1
ICD-10 Finland
Postencephalitic syndrome
+∞
8.3
8
*
G05.1*J11.8
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis in suspected influenza
+∞
8.3
8
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.3
8.3
21
34
N02BE01
ATC
paracetamol; systemic, rectal
1.6
8.3
757
6729
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
8.3
234
1589
WX730
NOMESCO Finland
Conventional respirator
5.0
8.2
25
51
P01BA02
ATC
hydroxychloroquine; oral
2.3
8.2
77
357
N03AE01
ATC
clonazepam; systemic
2.6
8.2
59
237
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.5
8.2
37
110
A02BC01
ATC
omeprazole; systemic
1.6
8.1
227
1539
N06AX11
ATC
mirtazapine; oral
1.6
8.1
271
1919
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
8.1
182
1158
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
33.6
8.1
10
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
33.6
8.1
10
*
G41.0
ICD-10 Finland
Grand mal status epilepticus
17.3
8.1
12
7
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
9.0
8.1
16
18
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
8.0
100
522
N03AX23
ATC
brivaracetam; systemic
22.2
8.0
11
5
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.5
8.0
35
102
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.9
7.9
46
164
R1260
NOMESCO Finland
Evaluation of communicative skills
5.5
7.9
22
41
R53
ICD-10 Finland
Malaise and fatigue
1.7
7.9
187
1212
N05CF01
ATC
zopiclone; oral
1.6
7.8
269
1917
R47.0
ICD-10 Finland
Dysphasia and aphasia
7.0
7.8
18
26
SPAT1216
SPAT
Assessment of functional ability
1.9
7.8
124
710
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
7.7
71
325
N06AX21
ATC
duloxetine; oral
2.0
7.7
97
509
A06AD11
ATC
lactulose; oral
1.9
7.6
121
689
G81.9
ICD-10 Finland
Hemiplegia, unspecified
6.2
7.6
19
31
J96.0
ICD-10 Finland
Acute respiratory failure
5.5
7.6
21
39
120
Kela drug reimbursment
Hypogammaglobulinaemia
80.7
7.4
8
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
7.4
81
402
J05AB01
ATC
aciclovir; systemic
1.7
7.4
175
1132
H53.1
ICD-10 Finland
Subjective visual disturbances
2.4
7.3
61
268
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
7.3
7
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
7.3
88
452
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
6.3
7.3
18
29
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
15.9
7.2
11
7
WX704
NOMESCO Finland
Intubation
2.2
7.2
73
351
A69.2
ICD-10 Finland
Lyme disease
2.6
7.2
48
187
N02AX02
ATC
tramadol; systemic, rectal
1.5
7.2
342
2613
C01CA24
ATC
epinephrine; parenteral
2.4
7.2
60
264
N03AX22
ATC
perampanel; oral
30.2
7.2
9
*
N02AA05
ATC
oxycodone; systemic
1.8
7.1
117
675
Z71.8
ICD-10 Finland
Other specified counselling
1.6
7.1
208
1423
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
7.0
92
490
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
7.0
88
461
XCK00
NOMESCO Finland
Perimetry
2.4
7.0
58
253
WX110
NOMESCO Finland
Local anesthesy
1.4
6.8
602
5171
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.9
6.8
39
137
B02.8
ICD-10 Finland
Zoster with other complications
11.0
6.8
12
11
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
5.4
6.8
19
36
N06AA09
ATC
amitriptyline; systemic
2.0
6.7
86
454
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
22.7
6.7
9
*
N01
ICPC
Headache
1.9
6.7
99
552
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
6.6
85
448
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
6.6
121
724
N05BA04
ATC
oxazepam; oral
1.6
6.5
208
1450
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.1
6.5
72
358
H53.2
ICD-10 Finland
Diplopia
3.0
6.5
35
120
N29
ICPC
Neurological sympt/complt other
3.9
6.5
25
66
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
6.5
117
699
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.7
6.5
17
30
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.0
6.5
34
115
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.2
6.5
62
289
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.5
6.4
46
187
WX872
NOMESCO Finland
Intensive care
2.5
6.4
48
198
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
4.9
6.4
19
39
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
6.4
109
638
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.6
6.3
42
164
A04
ICPC
Weakness/tiredness general
1.8
6.3
112
663
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
5.6
6.3
17
31
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
11.1
6.3
11
10
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
18.1
6.3
9
5
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
4.4
6.3
21
49
3238X
ICD-9 Finland
Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS, ENCEPHALOMYELITIS) ALIA DEF]
+∞
6.3
6
*
G41.8
ICD-10 Finland
Other status epilepticus
+∞
6.3
6
*
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
+∞
6.3
6
*
G05.0*A17.8
ICD-10 Finland
Tuberculous meningoencephalitis
+∞
6.3
6
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
6.2
99
564
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
26.9
6.2
8
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
26.9
6.2
8
*
G41.2
ICD-10 Finland
Complex partial status epilepticus
26.9
6.2
8
*
N05CD08
ATC
midazolam; nasal, systemic
3.6
6.2
26
74
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
6.2
61
290
N05AH03
ATC
olanzapine; systemic
2.2
6.2
58
268
XW000
NOMESCO Finland
Bone marrow biopsy
2.7
6.2
38
142
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.5
6.2
20
45
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
6.1
56
258
R03AC02
ATC
salbutamol; inhalant
1.4
6.1
445
3659
K93
ICPC
Pulmonary embolism
8.7
6.1
12
14
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.5
6.0
26
76
F05.8
ICD-10 Finland
Other delirium
6.7
6.0
14
21
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
10.1
6.0
11
11
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.4
6.0
49
213
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016018) Differential panel - Cerebral spinal fluid
209
80
32.16
311.11
1.6
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
219
49
55.82
307.65
1.3
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
297
184
21.89
307.65
1.8
1.5
e6/l
631.3
770.3
0.08
236
147
(3044290) Cell count panel - Cerebral spinal fluid
303
168
24.69
307.65
1.7
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
345
205
24.27
307.65
1.7
1.2
mg/l
673.4
440.7
9.31
338
195
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
340
181
26.97
307.65
1.6
1.2
mmol/l
3.6
3.7
0.70
325
171
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
297
184
21.89
307.65
1.7
1.4
e6/l
53.5
8.8
4.55
228
142
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
224
45
62.56
307.65
1.3
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
219
71
38.45
307.65
1.5
1.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
240
96
31.87
307.65
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
207
81
31.38
305.69
1.2
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
161
36
52.39
277.41
1.5
2.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
152
31
56.91
266.87
1.3
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
185
92
24.06
248.14
1.8
1.7
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
145
67
24.85
199.47
1.4
1.1
mg/l
56.4
39.2
1.63
129
53
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
139
63
25.18
192.55
1.3
1.0
mg/l
334.4
229.1
3.23
129
57
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
131
53
27.99
189.32
1.2
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
109
24
50.41
187.27
1.3
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
135
64
23.97
183.53
1.3
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
107
25
47.40
181.31
1.3
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
112
33
37.75
178.88
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
105
24
48.36
178.78
1.3
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
105
26
44.63
175.42
1.3
1.1
—
—
—
0
0
(4027681)
127
58
24.68
175.11
1.4
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
92
15
66.96
167.23
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
151
117
14.84
161.12
1.3
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
97
26
40.89
158.65
1.3
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
97
29
36.65
153.96
1.3
1.0
ng/l
306.8
29.0
—
46
5
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
293
593
6.41
145.48
2.7
2.4
au/ml
22.6
19.2
—
6
35
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
273
535
6.49
139.75
1.5
1.3
au/ml
39.8
31.8
—
6
27
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
105
55
21.04
136.19
1.5
1.0
u/l
1.1
1.1
0.03
50
31
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
70
18
41.52
115.23
1.2
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
63
10
66.84
114.48
1.5
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
67
17
41.95
110.60
1.3
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
77
33
25.05
108.06
1.1
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
273
671
5.11
106.82
3.4
2.6
g/l
9.8
10.6
2.29
253
616
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
164
253
7.46
104.44
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
100
92
11.88
95.05
1.5
1.8
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
53
12
46.40
89.63
1.4
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
51
11
48.61
87.14
1.4
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
52
14
38.97
84.27
1.2
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
51
14
38.19
82.20
1.2
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
50
14
37.40
80.14
1.2
1.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
81
75
11.60
76.43
3.1
2.1
e9/l
1.4
1.0
1.67
50
40
(3028679) Herpes simplex virus Ab [Presence] in Serum
63
39
17.09
74.98
1.3
1.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
67
53
13.41
69.70
3.2
2.2
e9/l
0.2
0.2
1.60
61
45
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
68
56
12.89
69.04
3.1
2.1
e6/l
525.6
455.2
0.37
61
46
(3014148) Varicella zoster virus Ab [Titer] in Serum
89
108
8.89
68.93
1.2
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
470
2179
3.05
68.12
5.5
4.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
64
55
12.31
63.23
2.9
1.9
%
13.7
12.3
0.24
40
26
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
59
51
12.18
58.02
2.9
2.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
481
2446
2.74
56.08
3.1
2.1
u/l
213.5
265.1
0.36
467
2307
(3018677) aPTT in Platelet poor plasma by Coagulation assay
309
1242
3.09
55.97
2.7
2.3
s
28.9
29.7
2.29
303
1203
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
64
66
10.25
55.88
2.7
2.1
e6/l
709.6
645.2
0.22
25
26
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
316
1313
2.99
53.69
2.0
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
68
81
8.89
53.28
1.6
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
523
2853
2.62
51.84
9.7
6.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
52
44
12.37
51.76
1.2
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
611
3618
2.59
50.60
8.8
6.4
mmol/l
1.2
1.2
2.28
566
3291
(3000060) B lymphocytes [#/volume] in Blood
41
24
17.72
49.91
2.7
2.1
e6/l
190.0
233.6
0.24
25
11
(21494815) CD4 cells/100 lymphocytes in Specimen
63
74
8.98
49.87
2.9
1.9
%
49.0
36.7
—
10
9
(3024561) Albumin [Mass/volume] in Serum or Plasma
588
3447
2.55
49.32
6.0
4.9
g/l
34.8
35.9
3.69
555
3210
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
47
38
12.89
48.07
1.4
1.1
miu/ml
1590.7
1561.3
0.04
47
38
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
647
4010
2.53
47.50
9.6
7.0
mmol/l
1.2
1.2
0.54
557
3399
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
115
271
4.63
45.62
4.7
1.5
g/l
0.2
0.2
3.58
107
260
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
49
5
102.60
45.16
1.2
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
95
192
5.33
45.16
3.1
3.8
umol/l
28.4
35.4
2.80
82
165
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
237
915
3.04
45.11
2.0
1.8
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
52
9
60.59
44.76
1.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
729
4858
2.54
44.49
7.5
5.0
mmol/l
6.6
6.6
0.02
700
4509
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
237
924
3.01
44.27
2.0
1.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
116
282
4.49
44.22
4.8
1.5
g/l
1.1
1.2
2.53
108
269
(3001604) Monocytes [#/volume] in Blood
669
4313
2.45
43.49
9.7
6.0
e9/l
0.6
0.6
1.72
592
3742
(3022096) Basophils/100 leukocytes in Blood
628
3940
2.42
43.36
9.9
6.1
%
0.6
0.7
0.49
601
3686
(3006315) Basophils [#/volume] in Blood
670
4329
2.44
43.24
9.7
6.0
e9/l
0.0
0.0
0.01
592
3759
(3006504) Eosinophils/100 leukocytes in Blood
636
4057
2.38
41.63
10.0
6.1
%
2.5
2.8
3.30
610
3791
(3019198) Lymphocytes [#/volume] in Blood
678
4452
2.41
41.45
9.7
6.0
e9/l
1.8
2.0
2.31
605
3929
(3019069) Monocytes/100 leukocytes in Blood
637
4082
2.37
41.03
10.3
6.3
%
8.7
8.5
0.90
612
3838
(3013115) Eosinophils [#/volume] in Blood
678
4484
2.38
40.28
10.5
6.3
e9/l
0.2
0.2
1.74
604
3949
(36304419) Bacteria [Presence] in Urine
416
2234
2.40
40.14
4.4
3.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
106
259
4.43
40.07
1.3
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
28
11
26.11
40.01
1.2
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
398
2099
2.42
39.97
5.1
4.0
%
90.3
91.8
0.61
390
2045
(3002030) Lymphocytes/100 leukocytes in Blood
646
4207
2.33
39.46
10.1
6.1
%
26.3
28.4
4.84
618
3936
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
28
12
23.93
38.75
1.4
5.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
637
4148
2.31
38.57
9.7
5.9
%
58.7
56.9
3.20
612
3901
(3030467) Casts [#/volume] in Urine by Automated count
416
2282
2.34
37.74
4.5
3.1
e6/l
0.3
0.4
1.64
330
1710
(3028026) IgM [Mass/volume] in Serum or Plasma
157
536
3.26
36.41
2.4
1.7
g/l
1.1
1.4
1.18
141
496
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
42
7
62.33
36.40
1.3
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
523
3191
2.24
36.39
8.3
8.9
inr
1.2
1.2
0.41
135
966
(3002582) Erythrocytes [#/volume] in Urine
441
2518
2.27
35.99
4.5
3.2
e6/l
30.5
84.3
1.23
353
1928
(3013650) Neutrophils [#/volume] in Blood by Automated count
717
4999
2.29
35.56
13.4
9.1
e9/l
4.3
4.1
1.32
638
4372
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
80
171
4.97
35.56
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
80
171
4.97
35.56
1.3
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
126
380
3.62
35.48
1.9
2.0
u/l
33.2
38.8
2.70
115
342
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
72
142
5.36
35.07
1.3
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
493
2971
2.21
34.98
5.3
3.7
e6/l
35.8
98.9
2.96
372
2071
(3018418) pH of Serum or Plasma
422
2388
2.26
34.97
5.1
3.9
ph
7.4
7.4
1.28
67
460
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
26
12
22.18
34.91
1.5
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
101
279
3.89
32.25
5.6
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
237
1078
2.54
31.91
7.7
6.1
mmol/l
1.0
1.1
0.32
218
1000
(3020630) Protein [Mass/volume] in Serum or Plasma
162
608
2.96
31.73
2.3
2.8
g/l
66.1
66.7
0.36
145
557
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
38
9
43.64
31.05
1.6
2.3
—
—
—
0
0
(3026782) Osmolality of Urine
312
1632
2.28
30.53
3.7
2.8
mosm/kgh2o
540.7
559.0
0.75
266
1404
(46235355) HIV 1 and 2 tests - Meaningful Use set
345
1882
2.22
30.47
1.8
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
94
258
3.90
30.26
2.3
2.8
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
34
5
70.03
30.05
1.1
1.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
757
5585
2.19
29.97
6.6
4.3
e6/l
388.0
1493.1
—
7
85
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
274
1370
2.34
29.71
4.0
2.8
e6/l
0.9
1.0
0.64
159
764
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
34
6
58.42
29.26
1.1
1.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
784
5891
2.21
29.24
6.9
4.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
33
6
56.65
28.28
1.4
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
137
500
2.99
28.07
2.1
2.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
261
1309
2.31
27.90
4.7
3.8
mmol/l
0.8
0.8
0.41
234
1236
(3000850) Epithelial cells [#/volume] in Urine
318
1731
2.19
27.84
3.2
2.6
e6/l
4.6
6.4
2.03
288
1528
(3027135) IgG subclass 1 [Mass/volume] in Serum
47
78
6.25
27.37
1.3
1.3
g/l
6.6
7.5
0.43
35
55
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
58
118
5.14
27.24
1.7
2.1
—
1744.0
—
0
5
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
195
870
2.52
27.00
4.6
4.4
u/l
281.3
251.2
0.43
180
820
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
256
1301
2.27
26.36
4.1
3.0
e6/l
3.0
2.6
0.19
140
698
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
259
3.66
26.28
2.0
2.6
g/l
10.7
10.4
0.15
68
225
(3024139) IgG subclass 3 [Mass/volume] in Serum
46
78
6.12
26.22
1.3
1.3
g/l
0.3
0.4
0.64
34
54
(3028192) IgG subclass 2 [Mass/volume] in Serum
46
78
6.12
26.22
1.3
1.3
g/l
2.9
2.7
0.19
34
54
(3036481) Cortisol [Moles/volume] in Serum or Plasma
185
820
2.52
25.91
2.5
2.0
nmol/l
349.1
370.5
0.85
172
762
(4062490)
46
80
5.96
25.56
1.3
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
48
89
5.60
24.95
1.1
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
82
235
3.69
24.76
1.9
2.2
mg/l
11.4
11.1
0.13
73
217
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
610
4344
1.93
24.17
7.2
6.2
umol/l
10.4
11.9
2.88
578
4108
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
821
6479
2.12
24.12
10.4
7.4
u/l
76.8
78.7
0.74
782
6103
(40758558) Short blood count panel - Blood
362
2167
2.01
23.98
9.8
6.7
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
29
7
42.46
23.70
1.4
4.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
279
3.39
23.43
2.0
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
279
3.39
23.43
2.0
2.5
g/l
3.9
3.7
0.30
61
207
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
279
3.39
23.43
2.0
2.5
g/l
7.2
7.4
0.41
62
218
(3000991) Gas panel - Venous blood
159
691
2.53
23.07
9.6
9.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
124
476
2.81
23.03
1.8
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
30
37
8.31
22.71
1.4
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
272
1492
2.10
22.71
3.7
3.7
ng/l
148.0
393.7
1.97
204
1105
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
29
9
33.06
22.49
1.4
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
158
696
2.49
22.24
7.8
8.1
mmol/l
8.3
9.1
0.76
149
662
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
263
3.38
22.15
2.0
2.6
g/l
3.0
3.1
0.17
63
211
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
75
219
3.61
22.01
1.8
2.7
g/l
36.9
38.1
0.66
59
193
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
476
3200
1.87
21.77
2.3
1.9
pmol/l
91.3
94.9
0.87
268
1675
(3024980) IgG subclass 4 [Mass/volume] in Serum
56
134
4.35
21.63
1.3
1.8
g/l
0.4
0.9
2.33
44
102
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
59
148
4.16
21.43
1.5
1.3
u/ml
3.3
5.7
0.69
36
59
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
36
59
6.28
21.21
3.4
2.6
%
44.7
44.4
0.02
17
16
(3021447) Carbon dioxide [Partial pressure] in Venous blood
167
771
2.38
21.15
4.5
4.3
kpa
5.7
5.8
0.43
162
750
(3026008) Bacteria identified in Urine by Culture
386
2445
1.90
21.10
4.0
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
166
766
2.38
21.04
4.5
4.3
mmol/l
1.6
1.8
0.39
137
609
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
69
197
3.67
20.93
1.9
2.9
g/l
0.0
0.0
0.00
58
184
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
25
27
9.46
20.92
3.6
2.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
89
299
3.15
20.92
1.8
1.6
iu/ml
0.2
0.1
0.39
23
57
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
27
9
30.72
20.62
1.2
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
69
199
3.64
20.62
1.9
2.8
g/l
0.0
0.0
0.00
58
185
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
110
422
2.79
20.40
5.1
4.9
mmol/l
23.4
24.1
1.39
101
385
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
71
212
3.51
20.14
1.9
2.8
g/l
0.1
0.0
0.19
60
198
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
54
133
4.22
20.09
1.5
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
179
874
2.26
19.83
10.1
8.7
mmol/l
1.3
1.0
0.37
138
688
(3019309) Folate [Moles/volume] in Red Blood Cells
254
1429
2.02
19.44
1.8
1.7
nmol/l
991.5
1180.2
3.07
197
1082
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
179
881
2.24
19.43
10.1
8.7
kpa
5.1
5.1
0.09
165
846
(3027801) Oxygen [Partial pressure] in Arterial blood
179
882
2.23
19.37
10.1
8.7
kpa
12.2
12.5
0.23
165
850
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
25
8
31.94
19.31
1.3
1.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
65
189
3.60
19.19
5.2
5.9
iu/ml
266.1
373.1
—
8
27
(3014111) Lactate [Moles/volume] in Serum or Plasma
158
742
2.32
19.16
8.7
7.7
mmol/l
1.4
1.4
0.12
146
705
(3009466) Valproate [Moles/volume] in Serum or Plasma
54
138
4.07
19.14
4.2
5.5
umol/l
335.4
371.5
1.01
46
119
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
86
299
3.04
19.05
2.0
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
74
237
3.28
18.81
1.9
2.8
g/l
1.6
0.9
0.45
60
213
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
23
6
39.14
18.60
1.0
1.0
—
—
—
0
0
(3036489) Thrombin time
93
343
2.87
18.54
2.9
2.4
s
22.3
21.3
0.41
86
312
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
55
147
3.89
18.33
1.5
1.2
u/ml
4.3
5.0
0.10
23
45
(21494814) CD8 cells/100 lymphocytes in Specimen
23
27
8.68
18.06
2.7
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
532
3844
1.76
18.05
13.4
9.2
e9/l
0.0
0.0
0.54
433
3148
(3024354) Oxygen [Partial pressure] in Venous blood
143
662
2.34
17.87
3.8
3.8
kpa
4.9
4.6
0.76
136
641
(3037522) Nuclear Ab [Titer] in Serum
217
1200
2.01
17.23
1.8
1.3
titre
384.7
475.3
0.72
68
247
(3013707) Erythrocyte sedimentation rate by Westergren method
772
6265
1.82
16.96
6.0
4.0
mm/h
13.3
11.3
3.14
728
5807
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
21
24
8.90
16.82
1.2
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
64
202
3.31
16.65
1.5
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
75
262
3.00
16.47
1.2
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
203
1114
2.01
16.40
1.7
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
81
299
2.85
16.11
3.1
2.6
%
98.2
91.5
1.43
75
282
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
412
2835
1.73
16.10
4.4
3.3
u/l
43.5
32.2
0.65
387
2709
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
39
89
4.51
16.00
1.3
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
402
2752
1.73
15.97
3.7
3.3
mmol/l
2.3
2.4
2.07
352
2436
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
87
337
2.72
15.80
2.5
2.1
g/l
1.7
1.5
0.90
72
297
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
21
8
26.73
15.62
1.1
1.0
u/l
2.0
—
—
6
0
(3006653) Thiamine [Moles/volume] in Blood
26
42
6.32
15.52
1.2
1.3
nmol/l
123.9
155.5
2.11
26
42
(3011397) Hemoglobin [Presence] in Urine by Test strip
302
1918
1.80
15.48
4.7
3.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
48
132
3.76
15.38
1.3
1.4
mmol/l
64.4
65.1
0.03
40
112
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
63
208
3.15
15.24
1.5
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
59
191
3.21
14.74
1.2
1.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
152
779
2.11
14.70
11.0
9.3
%
95.8
95.7
0.02
147
752
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
321
2103
1.75
14.66
2.4
2.2
mg/l
3.1
2.9
0.39
272
1788
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
474
3455
1.66
14.53
2.7
2.3
nmol/l
74.9
75.6
0.19
432
3128
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
52
159
3.39
14.24
1.2
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
301
1961
1.74
13.91
2.0
1.8
mg/l
1.1
1.1
0.21
234
1455
(3007853) Bacteria identified in Skin by Aerobe culture
180
1001
1.96
13.85
2.1
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
77
300
2.69
13.83
2.4
2.2
ug/l
0.7
2.3
0.99
70
264
(3027945) Reticulocytes/100 erythrocytes in Blood
163
882
2.00
13.55
2.9
2.9
%
1.8
1.8
0.06
141
801
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
719
5884
1.67
13.52
4.3
3.2
u/l
51.6
46.4
1.05
677
5530
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
119
574
2.21
13.39
1.8
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
283
1830
1.74
13.35
2.0
1.4
g/l
2.2
2.4
1.53
203
1134
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
429
3097
1.64
13.34
4.6
3.5
ng/l
42.2
40.4
0.06
297
2019
(4268621)
38
100
3.90
12.97
2.8
2.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
971
8717
2.14
12.87
25.2
13.4
mg/l
22.5
23.1
0.26
848
6832
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
48
151
3.28
12.58
1.6
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
59
210
2.91
12.55
1.2
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
37
98
3.87
12.52
1.2
1.3
—
—
—
0
0
(44790049)
38
103
3.79
12.46
1.6
1.6
—
—
—
0
0
(44790048)
38
103
3.79
12.46
1.6
1.6
—
—
—
0
0
(44790047)
38
103
3.79
12.46
1.6
1.6
—
—
—
0
0
(44806118)
38
103
3.79
12.46
1.6
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
46
143
3.32
12.29
1.1
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
366
2589
1.63
12.07
3.0
2.5
u/l
58.0
56.9
0.19
342
2413
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
31
74
4.28
12.05
1.1
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
16
20
8.11
11.90
1.2
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
23
43
5.44
11.86
1.0
1.0
ng/l
408.3
227.1
1.07
18
25
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
52
180
2.98
11.63
1.3
1.5
u/ml
90.6
101.7
—
8
35
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
63
243
2.69
11.55
1.8
1.2
u/ml
36.9
15.3
—
5
10
(3016650) Hepatitis A virus Ab [Presence] in Serum
47
154
3.15
11.55
1.1
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
11
0
+∞
11.48
1.1
0.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
25
52
4.90
11.47
1.2
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
543
4253
1.56
11.37
5.3
3.5
estimate
0.0
0.0
0.80
103
784
(3019550) Sodium [Moles/volume] in Serum or Plasma
966
8738
2.01
11.25
27.1
15.1
mmol/l
139.1
139.6
7.13
954
8507
(3035350) Ketones [Presence] in Urine by Test strip
536
4193
1.55
11.24
5.4
3.5
estimate
0.0
0.0
0.00
101
802
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
37
106
3.58
11.22
2.4
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
536
4196
1.55
11.19
7.5
4.8
estimate
0.0
0.0
0.50
105
813
(3034426) Prothrombin time (PT)
17
25
6.89
11.04
1.5
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
51
180
2.92
11.04
1.8
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
22
7.37
11.00
2.7
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
174
1028
1.83
10.97
1.4
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
108
3.51
10.91
1.3
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
275
1851
1.65
10.87
1.7
1.5
nmol/l
18.4
20.4
2.15
254
1588
(3021879) Hepatitis B virus core Ab [Presence] in Serum
136
744
1.95
10.87
1.6
1.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
22
43
5.20
10.82
1.0
1.0
ng/l
43.4
30.8
0.83
16
24
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
22
43
5.20
10.82
1.0
1.0
ng/l
618.8
614.6
0.01
16
26
(3042936) Bacteria identified in Isolate by Culture
194
1189
1.77
10.81
2.5
2.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
966
8764
1.98
10.75
27.1
15.2
mmol/l
3.9
4.0
0.92
950
8520
(3005322) IgE [Units/volume] in Serum or Plasma
110
561
2.07
10.70
1.4
1.3
u/ml
122.2
235.9
1.54
100
515
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
55
206
2.76
10.68
1.2
1.4
u/ml
301.6
234.7
0.55
33
120
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
58
224
2.68
10.62
1.6
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
140
780
1.91
10.59
2.9
2.5
g/l
0.2
0.2
0.98
126
737
(3008152) Bicarbonate [Moles/volume] in Arterial blood
95
460
2.17
10.57
10.0
8.3
mmol/l
25.0
24.3
1.05
89
432
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
25
56
4.55
10.52
1.4
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
88
416
2.21
10.39
11.6
10.8
mmol/l
24.4
24.4
0.02
77
393
(3023520) Reticulocytes [#/volume] in Blood
121
646
1.98
10.37
2.9
3.0
e9/l
68.2
71.4
0.42
87
497
(3044640) Blood type and Crossmatch panel - Blood
365
2656
1.57
10.35
2.8
2.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
46
159
2.98
10.34
2.9
4.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
234
1529
1.68
10.31
1.7
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
99
492
2.11
10.30
7.6
6.0
—
—
—
0
0
(3009343) pH of Capillary blood
109
565
2.03
10.14
4.6
4.4
ph
7.4
7.4
0.83
11
65
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
35
104
3.44
10.06
1.2
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
105
541
2.04
9.93
4.5
4.4
mmol/l
1.8
1.6
0.29
80
399
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
137
774
1.88
9.92
2.3
2.4
u/l
39.6
36.0
0.12
123
657
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
109
570
2.01
9.90
4.7
4.4
kpa
5.3
5.1
1.41
101
536
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
113
602
1.98
9.74
3.8
4.2
ng/l
79.6
81.1
0.07
96
539
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
84
401
2.19
9.68
13.6
12.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
32
93
3.52
9.52
1.4
1.6
mosm/kgh2o
279.3
281.7
0.16
23
64
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
880
7845
1.66
9.37
5.6
4.6
mu/l
1.8
2.0
0.86
826
7228
(3008536) Aspergillus sp Ab [Presence] in Serum
14
20
7.08
9.30
1.5
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
27
71
3.87
9.27
1.7
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
37
121
3.13
9.16
1.1
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
218
2.55
9.08
3.3
3.8
mg/l
35.5
78.0
0.80
47
172
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
54
218
2.55
9.08
3.3
3.8
mg/l
90.2
32.5
0.57
48
172
(3001186) Copper [Moles/volume] in Serum or Plasma
12
15
8.08
8.87
1.4
1.1
umol/l
16.4
17.8
0.36
12
15
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
48
185
2.67
8.86
1.5
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
55
228
2.49
8.76
1.9
1.2
u/ml
17.5
2.6
—
10
24
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
55
229
2.48
8.68
1.8
1.2
u/ml
5.4
10.5
0.41
12
35
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
754
6542
1.51
8.49
4.7
3.9
pmol/l
14.8
14.7
0.63
707
5974
(3004789) Transferrin [Mass/volume] in Serum or Plasma
182
1169
1.67
8.44
2.9
2.4
g/l
2.3
2.3
0.00
170
1082
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
32
103
3.17
8.15
1.6
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
82
416
2.05
8.10
4.6
4.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
170
1084
1.67
8.09
3.0
2.5
%
18.7
23.0
4.80
140
940
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
47
188
2.57
8.08
1.9
1.2
u/ml
35.0
36.7
—
6
15
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
36
125
2.94
8.07
1.7
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
56
245
2.36
7.96
3.4
3.4
u/ml
0.3
0.4
0.16
30
143
(3017181) Myelocytes/100 leukocytes in Blood
120
698
1.81
7.89
5.2
4.5
%
0.9
0.9
0.05
52
212
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
51
215
2.44
7.86
3.4
3.7
ratio
1.5
2.0
—
5
22
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
212
1441
1.59
7.79
3.5
2.9
mmol/l
2.4
2.4
0.35
180
1272
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
74
368
2.09
7.71
5.2
4.9
mmol/l
25.0
24.8
0.17
69
353
(3022948) Iron [Moles/volume] in Serum or Plasma
191
1269
1.61
7.71
2.9
2.4
umol/l
11.7
13.3
2.24
177
1172
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
488
3942
1.43
7.66
4.6
4.0
—
—
—
0
0
(4035726)
117
682
1.80
7.64
1.4
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
43
171
2.58
7.49
6.2
4.1
mmol/l
3.0
2.4
0.80
31
113
(3002179) Metamyelocytes/100 leukocytes in Blood
111
642
1.81
7.44
4.7
4.3
%
0.6
0.5
0.16
43
158
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
294
2168
1.49
7.39
3.1
3.1
ng/l
1080.8
1297.2
0.80
240
1830
(3048929) Epstein Barr virus Ab [Presence] in Serum
69
344
2.07
7.16
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
39
153
2.61
7.00
1.3
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
50
221
2.32
6.97
1.4
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
112
663
1.77
6.95
5.3
4.6
%
0.2
0.1
0.48
50
194
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
38
148
2.62
6.92
1.3
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
63
308
2.11
6.89
4.1
3.7
g/l
0.2
0.3
1.47
36
143
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
65
323
2.08
6.81
1.9
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
158
1032
1.62
6.80
1.5
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
44
186
2.42
6.78
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
63
311
2.09
6.72
1.3
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
276
2046
1.47
6.66
2.7
2.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
284
2120
1.46
6.61
3.3
2.6
umol/l
1637.3
5662.2
1.82
249
1845
(40759836) Histone Ab [Presence] in Serum by Immunoblot
24
74
3.29
6.58
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
24
74
3.29
6.58
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
24
74
3.29
6.58
1.4
1.1
—
—
—
0
0
(3010421) pH of Blood
47
209
2.31
6.48
6.0
3.9
ph
7.4
7.4
0.11
42
169
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
24
75
3.25
6.45
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
24
75
3.25
6.45
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
24
75
3.25
6.45
1.4
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
35
136
2.63
6.42
1.4
1.1
iu/ml
43397.7
77.6
—
6
30
(3025159) Blasts/100 leukocytes in Blood
105
628
1.74
6.29
5.1
4.6
%
0.0
0.1
1.18
44
168
(3008757) Leukocyte morphology finding [Identifier] in Blood
28
98
2.91
6.24
3.3
3.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
101
600
1.75
6.20
2.4
2.9
ng/l
186.4
204.5
0.13
92
540
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
89
510
1.81
6.16
1.7
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
110
671
1.71
6.15
4.5
3.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
41
176
2.38
6.13
5.1
4.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
23
74
3.15
5.91
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
23
74
3.15
5.91
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
23
74
3.15
5.91
1.2
1.7
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
22
69
3.23
5.89
1.1
1.1
nmol/l
0.1
1.3
—
5
12
(3035637) Corticotropin [Mass/volume] in Plasma
27
96
2.86
5.86
1.7
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
127
816
1.63
5.83
4.4
3.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
248
3239
0.70
5.80
2.7
2.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
466
3861
1.36
5.77
3.3
2.8
ug/l
136.2
115.0
0.74
426
3586
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
17
5.93
5.63
3.6
2.2
umol/l
16.2
15.9
—
10
17
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
18
51
3.57
5.62
1.5
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
144
964
1.57
5.57
28.6
20.8
inr
1.2
1.3
0.27
16
135
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
23
79
2.95
5.32
3.0
4.3
u/ml
52.0
56.2
—
5
21
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
142
958
1.56
5.31
3.2
3.1
umol/l
7.7
8.5
0.22
118
822
(4198724)
16
44
3.68
5.21
1.5
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
868
8008
1.43
5.08
20.8
12.0
ml/min/173m2
86.2
84.4
1.30
750
6532
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
167
1179
1.49
5.05
1.6
1.9
%
1.6
1.5
0.90
143
1051
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
13
32
4.10
4.90
3.0
3.2
umol/l
35.1
35.6
—
8
24
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
973
9198
1.59
4.90
16.0
9.9
u/l
27.8
26.7
1.02
946
8906
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
24
4.62
4.79
2.0
1.4
—
—
—
0
0
(4306422)
31
133
2.37
4.70
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
48
3.37
4.61
1.1
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
48
248
1.98
4.60
3.9
3.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
11
25
4.44
4.57
1.1
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
8
8
10.06
4.52
1.4
6.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
51
271
1.93
4.52
2.0
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
98
630
1.61
4.51
1.2
1.2
iu/ml
186.4
159.0
0.22
36
252
(3044889) 12 lead EKG panel
648
5761
1.31
4.49
3.9
3.6
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
16
49
3.30
4.48
10.4
8.1
u/ml
6688.7
42.5
—
7
16
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
49
3.30
4.48
1.1
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
24
94
2.59
4.40
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
678
6076
1.31
4.37
3.4
3.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
964
9135
1.52
4.33
20.8
12.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
6
11.73
4.28
1.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
36
172
2.13
4.27
6.3
3.3
—
—
—
0
0
(3019225) pH of Specimen
114
772
1.53
4.20
5.9
4.3
—
—
—
0
0
(3020891) Body temperature
54
302
1.83
4.12
6.4
4.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
89
573
1.60
4.09
2.7
2.5
e9/l
4.2
4.1
0.17
67
464
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
53
3.05
3.97
1.1
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
99
659
1.55
3.95
2.3
2.4
ug/l
4.4
7.7
2.61
81
580
(3012516) Albumin [Mass/volume] in Urine
276
2216
1.33
3.91
3.9
3.3
mg/l
1229.4
315.5
1.08
192
1426
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
31
145
2.17
3.89
1.2
1.1
—
—
—
0
0
(4010399)
90
589
1.58
3.87
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
81
518
1.61
3.84
3.2
3.4
pmol/l
4.3
4.6
1.41
70
457
(3009508) Creatinine [Moles/volume] in Urine
306
2500
1.31
3.82
4.3
3.2
mmol/l
7.6
7.9
0.45
260
2117
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
15
49
3.09
3.81
1.1
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
39
201
1.98
3.81
4.3
2.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
34
3.56
3.77
1.1
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
34
3.56
3.77
1.1
2.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
5
12.06
3.76
1.2
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
34
169
2.04
3.68
3.1
2.1
%
17.0
16.4
0.34
16
87
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
16
5.66
3.66
1.1
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
35
3.46
3.62
1.1
2.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
217
1708
1.34
3.49
1.6
1.7
pmol/l
35353965.2
46997633.6
0.12
198
1432
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
36
3.36
3.48
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
286
2342
1.30
3.47
4.9
4.0
mg/mmol
11.6
9.5
0.36
196
1495
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
14
5.75
3.34
1.1
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
43
3.05
3.25
1.1
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
43
3.05
3.25
1.1
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
43
3.05
3.25
1.1
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
43
3.05
3.25
1.1
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
389
3333
1.26
3.25
2.0
2.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
102
714
1.47
3.25
1.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
62
388
1.63
3.24
2.0
2.4
u/l
1754.5
3732.2
0.83
19
167
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
28
3.60
3.20
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
93
641
1.49
3.20
6.2
3.6
mmol/l
1.2
1.2
2.03
83
563
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
14
49
2.88
3.20
1.1
1.1
ratio
1.0
1.1
—
8
21
(40768446) Kidney Pathology biopsy report
11
33
3.36
3.20
1.4
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
8
15
5.36
3.19
1.6
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
232
1867
1.31
3.18
6.0
3.8
kg/l
1.0
1.0
0.13
44
257
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
67
2.56
3.13
1.1
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
793
7392
1.27
3.08
29.9
16.1
%
13.8
13.6
2.37
784
7242
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
16
5.03
3.05
2.4
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
29
3.47
3.05
1.1
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
45
2.91
3.03
1.4
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
13
45
2.91
3.03
1.4
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
23
107
2.17
2.98
3.4
2.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
17
69
2.49
2.97
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
866
8175
1.30
2.96
26.5
14.1
%
39.4
40.2
1.87
638
6169
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
95
2.23
2.91
1.2
1.4
pmol/l
290.2
362.6
0.40
14
74
(3024471) HLA-A [Type]
10
30
3.36
2.91
1.0
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
91
638
1.47
2.89
2.9
2.5
ml/min/173m2
77.6
68.2
0.28
40
260
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
22
4.12
2.88
1.3
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
29
150
1.96
2.87
3.3
2.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
37
208
1.81
2.85
1.7
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
67
985
0.66
2.80
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
186
1478
1.31
2.78
1.3
1.3
iu/ml
18.3
32.1
2.29
52
460
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
152
1.93
2.77
1.1
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
5
6
8.36
2.75
2.6
4.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
11
37
2.99
2.69
2.5
4.5
umol/l
88.2
137.0
—
6
23
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
19
86
2.23
2.65
1.1
1.2
u/l
54.8
62.5
0.19
12
59
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
80
2.27
2.61
2.6
2.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
15
4.69
2.60
1.0
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
128
1.98
2.57
2.6
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
16
68
2.37
2.56
1.6
2.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
56
2.52
2.53
1.7
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
51
325
1.60
2.53
1.3
1.3
miu/ml
211.6
251.9
0.25
19
153
(3030905) Polymorphonuclear cells [#/volume] in Blood
31
172
1.83
2.52
4.4
3.5
e9/l
4.0
4.2
0.25
31
172
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
812
7664
1.24
2.42
6.3
5.4
mmol/mol
40.0
39.4
0.75
757
7149
(40765096) Chromosome analysis panel by Banding
8
22
3.66
2.36
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
18
84
2.16
2.35
3.7
3.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
43
269
1.62
2.32
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
43
269
1.62
2.32
1.3
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
265
2249
1.24
2.30
6.0
3.8
estimate
0.0
0.0
1.08
100
793
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
32
185
1.75
2.30
1.4
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
802
7576
1.23
2.28
30.2
16.8
g/l
332.9
333.0
0.07
795
7523
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
41
2.70
2.28
1.1
1.8
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
13
4.63
2.27
3.8
5.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
66
2.29
2.25
1.1
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
179
1.75
2.24
5.0
3.8
%
57.5
56.7
0.14
31
179
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
37
225
1.67
2.23
1.9
1.9
iu/l
7.6
5.9
0.34
13
76
(42529406) Shigella sp [Presence] in Stool by Culture
43
273
1.60
2.20
1.3
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
42
2.64
2.19
1.1
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
61
2.31
2.15
3.9
3.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
17
81
2.12
2.13
1.5
1.4
mmol/l
11.2
12.6
—
10
17
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
18
88
2.06
2.12
1.7
2.0
nmol/l
16.6
20.8
1.76
18
83
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
43
2.57
2.10
1.7
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
43
2.57
2.10
1.7
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
24
131
1.85
2.09
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
14
62
2.27
2.08
1.1
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
17
82
2.09
2.07
5.4
3.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
72
519
1.41
2.04
4.6
2.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
15
4.02
2.04
1.2
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
368
3263
1.19
2.02
6.0
3.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
44
2.52
2.01
3.1
2.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
10
38
2.65
2.01
1.9
5.3
mg/l
72.4
66.4
—
10
26
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
242
2063
1.22
2.00
1.3
1.3
u/ml
2.7
1.5
0.27
46
554
(3025941) Bacteria identified in Stool by Culture
68
487
1.42
2.00
1.4
1.2
—
—
—
0
0
(4024509)
13
57
2.30
1.98
1.7
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
40
605
0.65
1.97
1.3
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
89
670
1.36
1.96
2.1
2.2
nmol/l
13.2
13.1
0.02
79
606
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
91
1.99
1.96
3.3
2.5
mg/l
18.5
22.6
—
6
24
(40768443) Skin Pathology biopsy report
49
333
1.49
1.90
1.1
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
9
34
2.66
1.86
1.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
34
2.66
1.86
2.8
3.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
30
182
1.67
1.86
2.5
2.0
g/l
129.6
130.5
0.06
19
135
(3045142) Bone marrow Pathology biopsy report
17
86
1.99
1.85
1.4
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
17
3.54
1.84
1.3
1.8
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
12
4.18
1.82
1.2
1.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
35
2.58
1.80
3.2
2.5
ug/l
40.6
90.5
—
9
35
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
23
3.06
1.80
1.1
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
29
2.77
1.79
6.3
3.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
109
1.85
1.78
1.4
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
32
201
1.61
1.76
1.9
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
232
2001
1.20
1.70
7.1
4.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
19
3.17
1.66
1.2
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
20
112
1.80
1.65
1.9
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
14
3.58
1.61
1.2
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
14
3.58
1.61
2.4
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
14
3.58
1.61
4.6
2.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
32
2.51
1.60
2.5
3.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
106
1.81
1.59
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
106
1.81
1.59
1.4
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
43
297
1.47
1.58
1.9
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
11
50
2.21
1.57
1.4
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1000
9775
1.31
1.56
34.6
19.4
e9/l
7.0
6.7
3.41
979
9516
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
153
1278
1.23
1.55
2.2
2.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
107
1.79
1.55
1.4
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
107
1.79
1.55
1.4
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
999
9765
1.31
1.55
34.6
19.4
e9/l
255.8
251.9
1.00
982
9532
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
15
3.34
1.52
1.4
1.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
999
9769
1.31
1.51
34.5
19.3
fl
90.9
90.6
1.36
987
9640
(3035941) MCH [Entitic mass]
999
9770
1.30
1.50
34.4
19.3
pg
30.3
30.2
0.65
986
9640
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
101
1.80
1.49
1.1
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
999
9771
1.30
1.49
34.6
19.4
e12/l
4.4
4.5
9.19
976
9516
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
140
1165
1.23
1.48
2.0
2.0
—
—
—
0
0
(4211845)
9
37
2.44
1.48
2.6
2.8
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
9
37
2.44
1.48
1.6
1.6
—
1224630.0
—
0
5
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
109
1.76
1.47
1.4
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
117
955
1.25
1.47
9.7
6.7
—
—
—
0
0
(3004451) EKG impression Narrative
9
38
2.38
1.45
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
24
148
1.64
1.45
1.1
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
999
9776
1.30
1.44
34.8
19.5
g/l
132.9
136.1
9.50
986
9641
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
40
2.26
1.40
1.2
1.2
u/l
416.2
486.4
—
9
35
(3048689) Calprotectin [Mass/mass] in Stool
134
1118
1.23
1.39
2.5
2.5
ug/g
205.9
131.4
0.61
107
898
(1001926) Buprenorphine [Presence] in Urine by Screen method
49
357
1.39
1.38
3.7
1.9
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
17
2.95
1.36
3.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
35
2.30
1.27
1.5
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
35
2.30
1.27
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
47
346
1.37
1.26
2.2
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
70
881
0.78
1.22
1.6
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
71
1.84
1.19
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
13
71
1.84
1.19
1.0
1.2
u/ml
0.2
0.4
—
5
28
(3000570) Elastase.pancreatic [Mass/mass] in Stool
33
231
1.44
1.18
1.7
1.4
ug/g
263.9
316.2
0.51
18
130
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
51
388
1.33
1.14
2.9
2.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
40
2.01
1.12
2.9
2.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
26
374
0.69
1.09
1.2
1.7
mg/l
3.1
3.2
0.03
17
264
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
41
1.96
1.09
5.3
3.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
41
1.96
1.09
1.4
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
32
2.19
1.08
1.0
1.0
%
100.1
123.4
—
7
32
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
229
0.61
1.06
1.5
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
33
2.13
1.05
2.6
1.7
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
34
2.07
1.03
1.4
1.1
%
117.4
108.6
—
7
29
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
36
264
1.38
1.03
1.4
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
48
1.88
1.00
1.3
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
17
107
1.60
1.00
2.1
2.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
268
2438
1.13
0.99
3.7
4.6
ug/l
2.4
2.6
0.14
249
2185
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
204
1824
1.15
0.98
1.7
1.6
—
—
—
0
0
(44806420)
5
23
2.18
0.98
2.8
2.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
50
1.81
0.96
2.3
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
62
499
1.26
0.94
1.2
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
287
1.34
0.92
1.6
1.4
u/l
10.7
9.4
0.22
31
231
(3027456) Digoxin [Moles/volume] in Serum or Plasma
20
134
1.50
0.92
4.5
3.0
nmol/l
0.8
0.9
0.54
12
106
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
28
201
1.40
0.92
2.2
2.5
ug/min
91.9
108.5
0.14
19
125
(3011288) Drugs identified in Urine by Screen method
40
305
1.32
0.91
8.1
2.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
18
118
1.53
0.91
1.8
1.4
—
—
—
0
0
(3013512) EKG study
250
2281
1.12
0.89
4.3
3.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
49
388
1.28
0.86
6.0
3.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
72
1.67
0.85
2.0
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
84
708
1.20
0.85
2.0
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
80
1.63
0.84
1.1
1.4
titre
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
31
1.94
0.84
1.7
1.6
—
—
—
0
0
(3036603) Volume of Urine
10
57
1.76
0.83
1.4
1.6
—
1745.8
—
0
9
(3045424) Erythrocytes [Presence] in Urine
20
138
1.46
0.82
1.7
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
33
1.82
0.79
3.3
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
25
0.00
0.79
0.0
1.0
—
23.3
—
0
25
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
175
0.62
0.78
1.6
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
52
422
1.24
0.77
3.7
2.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
24
174
1.39
0.77
2.3
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
86
736
1.18
0.76
6.2
3.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
40
502
0.79
0.75
1.5
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
256
2363
1.11
0.74
5.2
3.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
25
2.00
0.72
2.6
5.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
9
58
1.56
0.70
1.2
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
127
1130
1.14
0.69
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
111
980
1.15
0.68
3.9
4.2
%
31.3
31.7
0.12
86
666
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
203
0.69
0.67
2.1
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
86
1.52
0.66
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
171
1.35
0.66
1.7
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
12
78
1.54
0.65
1.2
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
44
1.59
0.65
7.1
7.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
44
1.59
0.65
1.1
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
79
1.52
0.62
1.6
2.3
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.7
—
94.2
—
0
12
(3000764) Benzodiazepines [Presence] in Urine
54
455
1.20
0.59
3.6
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
64
1.57
0.58
2.3
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
19
140
1.36
0.58
1.2
1.2
u/l
134.9
36.6
0.38
14
124
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
154
1404
1.11
0.58
1.3
1.3
u/ml
5.0
11.8
1.54
52
551
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
819
8357
0.92
0.58
4.4
4.1
mmol/l
1.4
1.5
2.13
754
7736
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
66
569
1.17
0.57
2.0
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
37
1.63
0.55
1.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
65
1.54
0.55
2.2
5.8
%
10.6
11.3
—
10
65
(3047189) Immunofixation for 24 hour Urine
6
38
1.58
0.54
1.0
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
54
460
1.18
0.54
3.6
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
108
1.39
0.53
3.0
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
214
1.27
0.52
1.5
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
54
462
1.18
0.52
3.6
2.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
83
1.45
0.52
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
23
179
1.29
0.51
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
23
179
1.29
0.51
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
65
1.39
0.50
1.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
15
110
1.37
0.49
3.0
2.7
mmol/l
4.1
4.1
0.36
15
110
(3035285) Chloride [Moles/volume] in Venous blood
15
110
1.37
0.49
3.0
2.7
mmol/l
103.4
105.2
0.38
15
110
(3008898) HLA-B27 [Presence]
30
366
0.81
0.48
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
24
191
1.26
0.46
1.8
1.7
e6/l
10029.5
14300.8
0.32
19
141
(3050129) First trimester maternal screen panel - Serum or Plasma
27
331
0.81
0.46
1.7
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
56
487
1.16
0.46
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
262
2480
1.07
0.45
1.5
1.5
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
12
164
0.73
0.45
1.1
1.1
u/ml
3.1
4.3
—
7
41
(40768441) Liver Pathology biopsy report
10
69
1.45
0.44
1.9
1.5
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
7
51
1.37
0.44
1.0
1.3
ug/l
8.5
6.0
—
7
40
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
830
8161
1.07
0.44
4.7
4.2
mmol/l
6.0
5.9
0.74
765
7469
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
56
1.43
0.42
1.6
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
32
1.57
0.42
1.4
12.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
70
1.43
0.41
1.4
1.5
g/l
1.0
1.0
—
10
70
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
96
1.36
0.41
1.1
1.2
nmol/l
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
2.6
1.4
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
15
0.00
0.41
0.0
1.3
—
3.5
—
0
6
(3027944) Amphetamines [Presence] in Urine
52
455
1.15
0.41
2.1
1.9
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
1.4
—
0
11
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
34
1.47
0.40
3.0
2.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
60
1.34
0.40
1.4
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
18
142
1.27
0.38
1.6
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
48
420
1.15
0.38
1.3
1.4
iu/l
34.2
24.6
0.94
38
345
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
68
1.33
0.37
1.4
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
147
0.75
0.37
8.4
2.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
224
0.80
0.37
1.4
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
146
0.75
0.36
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
223
0.80
0.36
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
6
42
1.43
0.35
1.5
2.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
42
1.43
0.35
1.8
1.1
iu/ml
132.9
252.0
—
6
42
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
134
0.74
0.35
2.3
3.2
u/ml
3.9
34.6
—
10
127
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
297
0.84
0.34
1.5
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
200
1.20
0.34
1.1
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
151
1420
1.07
0.33
2.7
2.8
ug/l
0.8
0.8
0.03
104
882
(3044242) Glucose [Moles/volume] in Arterial blood
6
46
1.31
0.33
1.5
3.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
187
0.80
0.32
1.2
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
830
8404
0.95
0.31
4.4
4.2
mmol/l
4.6
4.7
1.91
765
7821
(3015183) Erythrocyte sedimentation rate
7
54
1.30
0.30
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
35
306
1.15
0.30
3.0
2.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
102
1.28
0.30
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
46
514
0.89
0.30
1.3
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
57
1.23
0.29
1.4
1.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
173
0.81
0.28
1.1
1.1
u/ml
12.7
4.6
—
8
99
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
83
770
1.08
0.27
3.2
4.2
ug/l
4.1
27.9
1.47
61
633
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
203
1944
1.05
0.26
3.4
4.0
%
21.2
21.0
0.08
88
870
(1002224) Polysomnography panel
43
386
1.12
0.26
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
39
348
1.13
0.26
1.8
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
97
909
1.07
0.25
1.3
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
191
0.84
0.24
1.1
1.1
u/ml
0.6
2.7
—
9
83
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
799
8077
0.96
0.23
4.0
3.7
mmol/l
1.4
1.3
2.19
734
7449
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
846
8541
0.96
0.23
4.9
4.5
mmol/l
2.7
2.8
2.28
774
7899
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
94
999
0.94
0.23
1.9
1.8
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
79
1.27
0.22
1.5
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
42
1.19
0.21
1.4
3.7
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.1
—
0
6
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
2.5
—
0.5
—
0
11
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
173.2
—
0
10
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
3.1
—
0
5
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.6
—
0
6
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
7
(3000285) Sodium [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
166
0.84
0.20
1.1
1.1
u/ml
1.5
1.3
—
7
76
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
113
0.79
0.20
1.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
52
1.15
0.19
1.2
1.4
—
250.0
—
0
6
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
144
1382
1.05
0.19
1.6
1.4
—
—
—
0
0
(4034850)
24
269
0.89
0.18
10.4
10.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
25
279
0.89
0.18
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
279
0.89
0.18
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
25
279
0.89
0.18
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
92
874
1.06
0.18
1.9
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
103
1079
0.95
0.17
1.2
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
278
0.90
0.17
1.3
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
15
172
0.87
0.15
1.6
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
102
1.18
0.15
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
131
1.15
0.14
1.7
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
84
1.19
0.14
3.0
2.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
324
0.92
0.12
1.7
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
23
210
1.10
0.12
9.7
4.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
16
143
1.12
0.11
1.1
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
229
0.92
0.11
1.3
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
29
270
1.08
0.10
1.1
1.1
u/ml
1.7
6.5
—
5
35
(44813793)
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
64
0.78
0.08
1.2
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
7
64
1.09
0.08
1.1
1.1
—
7.4
—
0
14
(40768795) Lymph node Pathology biopsy report
8
74
1.08
0.07
1.6
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
28
296
0.94
0.07
1.4
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
87
1.03
0.07
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
214
2169
0.98
0.06
1.8
1.6
mmol/l
1.5
1.4
0.59
188
1847
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
100
1.10
0.05
2.7
2.4
pg
33.1
33.2
0.03
11
100
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
103
1048
0.98
0.04
1.4
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
15
140
1.07
0.04
1.9
2.8
umol/l
7.6
6.9
—
8
105
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
128
0.94
0.02
1.1
1.1
u/ml
2.5
4.3
—
7
48
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
148
0.95
0.02
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
148
0.95
0.02
1.0
1.0
u/ml
3.9
2.0
—
6
67
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
143
1.05
0.01
1.3
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
55
542
1.02
0.01
1.2
1.2
—
—
—
0
0
(4094501)
20
206
0.97
0.00
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
103
0.97
0.00
1.0
1.1
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
14.3
—
0
6
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
372.6
—
0
5
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
56
0.89
0.00
1.0
2.2
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
9
0.00
0.00
0.0
4.0
—
14.3
—
0
9
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.9
—
0
5
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
2.0
—
1338.4
—
0
5
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
7
74
0.95
0.00
1.6
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.8
—
4.6
—
0
5
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
68
0.88
0.00
1.5
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
68
0.88
0.00
1.5
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ENCEPHALITIS – Encephalitis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).